KESTRA MEDICAL TECHNOLOGIES, LTD.

KMTS · NASDAQ
Analyze with AI
10/31/2025
7/31/2025
4/30/2025
1/31/2025
Operating Activities
Net Income-$32,785-$25,826-$51,111-$21,759
Dep. & Amort.$2,373$2,028$1,836$1,888
Deferred Tax$0$0$0$0
Stock-Based Comp.$8,653$4,579$22,312$459
Change in WC$0-$5,981-$3,460$123
Other Non-Cash$3,416-$1,074$6,724$905
Operating Cash Flow-$18,343-$26,274-$23,699-$18,384
Investing Activities
PP&E Inv.-$7,265-$8,166-$8,044-$4,063
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$155-$66$283$0
Investing Cash Flow-$7,420-$8,232-$7,761-$4,063
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0-$6-$50
Other Fin. Act.-$27-$1,875$239,709-$69
Financing Cash Flow-$27-$1,875$214,703-$119
Forex Effect$0$0$0$0
Net Chg. in Cash-$25,790-$36,381$183,243-$22,566
Supplemental Information
Beg. Cash$201,548$237,929$54,686$77,252
End Cash$175,758$201,548$237,929$54,686
Free Cash Flow-$25,608-$34,440-$31,743-$22,447
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) Financial Statements & Key Stats | AlphaPilot